Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Find the Interesting Universe of Computerized reasoning: the Capability of man-made intelligence - 2Elite Execution Wall televisions for Film Darlings
- 3Record-breaking 'space laser' erupts from merging galaxies 8 billion light-years away
- 4The most effective method to Keep up with Proficient Handshakes in a Computerized World
- 5Chinese fossils reveal a primordial burst of animal evolution
- Artemis II shares new lunar images while more than halfway to the moon
- German police 'cleared path for fascists with batons,' protesters say
- When a sperm whale gives birth, the mother gets help from her friends
- Step by step instructions to Lessen Your Gamble of Creating Cellular breakdown in the lungs
- The Best Cell phone Brands for Tech Lovers
- High velocity Internet services for Metropolitan Regions
- Step by step instructions to Integrate Lab Precious stones into Special Adornments Pieces
- Novo Nordisk gears up for December Ozempic launch in India, sources say
- Lawsuit claims ChatGPT exacerbated man's delusions leading to murder-suicide
